CervoMed Inc. Other Nonoperating Income (Expense)
CervoMed Inc. (CRVO) reported Other Nonoperating Income (Expense) of $2.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-07
- CervoMed Inc. other nonoperating income (expense) for the quarter ending 2026-06-30 was $2.00K.
- CervoMed Inc. other nonoperating income (expense) for the quarter ending 2026-03-31 was -$1.02K.
- CervoMed Inc. other nonoperating income (expense) for the quarter ending 2025-12-31 was $3.29K, a 20.73% increase year-over-year.
- CervoMed Inc. other nonoperating income (expense) for the quarter ending 2025-09-30 was -$1.23K.
- CervoMed Inc. other nonoperating income (expense) for fiscal 2025 was -$8.33K.
- CervoMed Inc. other nonoperating income (expense) for fiscal 2024 was -$991.00, a 100.02% decline from fiscal 2023.
- CervoMed Inc. other nonoperating income (expense) for fiscal 2023 was $5.42M.
- CervoMed Inc. other nonoperating income (expense) for fiscal 2022 was -$2.39M.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 6 month as first filed | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 9 month as first filed | Other Nonoperating Income (Expense) 12 month | Other Nonoperating Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.00K 10-Q · filed 2026-08-07 | $977.00 10-Q · filed 2026-08-07 | $4.27K derived: sum of 3 quarters · filed 2026-08-07 | $3.04K derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | -$1.02K 10-Q · filed 2026-05-15 | $2.27K derived: sum of 2 quarters · filed 2026-05-15 | $1.04K derived: sum of 3 quarters · filed 2026-05-15 | -$9.21K derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | $3.29K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $2.06K derived: sum of 2 quarters · filed 2026-03-13 | -$8.19K derived: sum of 3 quarters · filed 2026-08-07 | -$8.33K 10-K · filed 2026-03-13 | ||||
| 2025-09-30 | -$1.23K 10-Q · filed 2025-11-07 | -$11.48K derived: sum of 2 quarters · filed 2026-08-07 | -$11.62K 10-Q · filed 2025-11-07 | -$8.89K derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | -$10.26K 10-Q · filed 2026-08-07 | -$10.39K 10-Q · filed 2026-08-07 | -$7.67K derived: sum of 3 quarters · filed 2026-08-07 | -$11.11K derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | -$135.00 10-Q · filed 2026-05-15 | $2.59K derived: sum of 2 quarters · filed 2026-05-15 | -$849.00 derived: sum of 3 quarters · filed 2026-05-15 | -$1.10K derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $2.73K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$714.00 derived: sum of 2 quarters · filed 2026-03-13 | -$961.00 derived: sum of 3 quarters · filed 2026-03-13 | -$991.00 10-K · filed 2026-03-13 | ||||
| 2024-09-30 | -$3.44K 10-Q · filed 2025-11-07 | -$3.69K derived: sum of 2 quarters · filed 2025-11-07 | -$3.72K 10-Q · filed 2025-11-07 | -$4.32K derived: sum of 4 quarters · filed 2025-11-07 | ||||
| 2024-06-30 | -$247.00 10-Q · filed 2025-08-08 | -$277.00 10-Q · filed 2025-08-08 | -$877.00 derived: sum of 3 quarters · filed 2025-08-08 | $4.78M derived: sum of 4 quarters · filed 2025-08-08 | ||||
| 2024-03-31 | -$30.00 10-Q · filed 2025-05-12 | -$630.00 derived: sum of 2 quarters · filed 2025-05-12 | $4.78M derived: sum of 3 quarters · filed 2025-05-12 | $4.56M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | -$600.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $4.78M derived: sum of 2 quarters · filed 2025-03-17 | $4.57M derived: sum of 3 quarters · filed 2025-03-17 | $5.42M 10-K · filed 2025-03-17 | ||||
| 2023-09-30 | $4.78M 10-Q · filed 2024-11-12 | $4.57M derived: sum of 2 quarters · filed 2024-11-12 | $5.42M 10-Q · filed 2024-11-12 | $4.80M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | -$212.21K 10-Q · filed 2024-08-09 | $644.37K 10-Q · filed 2024-08-09 | $24.31K derived: sum of 3 quarters · filed 2024-08-09 | $24.22K derived: sum of 4 quarters · filed 2024-08-09 | ||||
| 2023-03-31 | $856.58K 10-Q · filed 2024-05-14 | $236.52K derived: sum of 2 quarters · filed 2024-05-14 | $236.43K derived: sum of 3 quarters · filed 2024-05-14 | |||||
| 2022-12-31 | -$620.06K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$620.15K derived: sum of 2 quarters · filed 2024-03-29 | -$2.39M 10-K · filed 2024-03-29 | |||||
| 2022-09-30 | -$88.00 10-Q · filed 2023-11-13 | -$1.77M 10-Q · filed 2023-11-13 | ||||||
| 2015-12-31 | $1.04K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $2.20K derived: sum of 2 quarters · filed 2016-03-25 | $3.84K derived: sum of 3 quarters · filed 2016-03-25 | $6.36K 10-K · filed 2016-03-25 | ||||
| 2015-09-30 | $1.17K 10-Q · filed 2015-11-12 | $2.80K derived: sum of 2 quarters · filed 2015-11-12 | $5.32K 10-Q · filed 2015-11-12 | $27.12K derived: sum of 4 quarters · filed 2016-03-25 | ||||
| 2015-06-30 | $1.63K 10-Q · filed 2015-08-12 | $4.15K 10-Q · filed 2015-08-12 | $25.96K derived: sum of 3 quarters · filed 2016-03-25 | $29.11K derived: sum of 4 quarters · filed 2016-03-25 | ||||
| 2015-03-31 | $2.52K 10-Q · filed 2015-05-11 | $24.32K derived: sum of 2 quarters · filed 2016-03-25 | $27.48K derived: sum of 3 quarters · filed 2016-03-25 | $29.94K derived: sum of 4 quarters · filed 2016-03-25 | ||||
| 2014-12-31 | $21.80K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $24.95K derived: sum of 2 quarters · filed 2016-03-25 | $27.42K derived: sum of 3 quarters · filed 2016-03-25 | $25.40K 10-K · filed 2016-03-25 | ||||
| 2014-09-30 | $3.15K 10-Q · filed 2015-11-12 | $149.15K 10-Q · filed 2014-11-12 | $5.62K derived: sum of 2 quarters · filed 2015-11-12 | $3.60K 10-Q · filed 2015-11-12 | $387.72K 10-Q · filed 2014-11-12 | -$639.70K derived: sum of 4 quarters · filed 2015-11-12 | ||
| 2014-06-30 | $2.47K 10-Q · filed 2015-08-12 | $188.94K 10-Q · filed 2014-08-14 | $446.00 10-Q · filed 2015-08-12 | $238.57K 10-Q · filed 2014-08-14 | -$642.85K derived: sum of 3 quarters · filed 2015-08-12 | -$593.41K derived: sum of 4 quarters · filed 2015-08-12 | ||
| 2014-03-31 | $49.64K 10-Q · filed 2015-05-11 | -$49.64K 10-Q · filed 2014-05-20 | -$645.32K derived: sum of 2 quarters · filed 2015-05-11 | -$595.88K derived: sum of 3 quarters · filed 2015-05-11 | -$613.51K derived: sum of 4 quarters · filed 2015-05-11 | |||
| 2013-12-31 | -$694.96K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-03 | -$645.51K derived: sum of 2 quarters · filed 2015-04-03 | -$663.15K derived: sum of 3 quarters · filed 2015-04-03 | -$660.59K 10-K · filed 2015-04-03 | -$71.63K 10-K/A · filed 2014-04-23 | |||
| 2013-09-30 | $49.44K 10-Q · filed 2014-11-12 | -$51.44K 10-Q · filed 2013-11-19 | $31.81K derived: sum of 2 quarters · filed 2014-11-12 | $34.37K 10-Q · filed 2014-11-12 | -$54.50K 10-Q · filed 2013-11-19 | -$218.49K derived: sum of 4 quarters · filed 2014-11-12 | ||
| 2013-06-30 | -$17.64K 10-Q · filed 2014-08-14 | -$15.07K 10-Q · filed 2014-08-14 | -$267.94K derived: sum of 3 quarters · filed 2014-08-14 | |||||
| 2013-03-31 | -$2.56K 10-Q · filed 2014-05-20 | -$250.30K derived: sum of 2 quarters · filed 2014-05-20 | ||||||
| 2012-12-31 | -$247.74K derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-04-23 | $379.19K 10-K/A · filed 2014-04-23 | ||||||
| 2012-09-30 | $626.93K 10-Q · filed 2013-11-19 | |||||||
| 2012-06-30 | -$133.77K 10-Q · filed 2013-11-19 | |||||||
| 2011-12-31 | -$1.01M 10-K/A · filed 2013-04-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |